84 related articles for article (PubMed ID: 20488703)
1. Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294.
Carneiro EO; Andrade CH; Braga RC; Tôrres AC; Alves RO; Lião LM; Fraga CA; Barreiro EJ; de Oliveira V
Bioorg Med Chem Lett; 2010 Jun; 20(12):3734-6. PubMed ID: 20488703
[TBL] [Abstract][Full Text] [Related]
2. CYP1A2-mediated biotransformation of cardioactive 2-thienylidene-3,4-methylenedioxybenzoylhydrazine (LASSBio-294) by rat liver microsomes and human recombinant CYP enzymes.
Fraga AG; da Silva LL; Fraga CA; Barreiro EJ
Eur J Med Chem; 2011 Jan; 46(1):349-55. PubMed ID: 21144625
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues.
Silva AG; Zapata-Sudo G; Kummerle AE; Fraga CA; Barreiro EJ; Sudo RT
Bioorg Med Chem; 2005 May; 13(10):3431-7. PubMed ID: 15848755
[TBL] [Abstract][Full Text] [Related]
4. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.
Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ
Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor.
Leal CM; Pereira SL; Kümmerle AE; Leal DM; Tesch R; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Eur J Med Chem; 2012 Sep; 55():49-57. PubMed ID: 22857782
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-platelet activity of novel arylsulfonate--acylhydrazone derivatives, designed as antithrombotic candidates.
Lima LM; Frattani FS; Dos Santos JL; Castro HC; Fraga CA; Zingali RB; Barreiro EJ
Eur J Med Chem; 2008 Feb; 43(2):348-56. PubMed ID: 17532545
[TBL] [Abstract][Full Text] [Related]
7. Combination of docking, molecular dynamics and quantum mechanical calculations for metabolism prediction of 3,4-methylenedioxybenzoyl-2-thienylhydrazone.
Braga RC; Alves VM; Fraga CA; Barreiro EJ; de Oliveira V; Andrade CH
J Mol Model; 2012 May; 18(5):2065-78. PubMed ID: 21901409
[TBL] [Abstract][Full Text] [Related]
8. 6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction.
Diaz P; Phatak SS; Xu J; Astruc-Diaz F; Cavasotto CN; Naguib M
J Med Chem; 2009 Jan; 52(2):433-44. PubMed ID: 19115816
[TBL] [Abstract][Full Text] [Related]
9. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives.
Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783
[TBL] [Abstract][Full Text] [Related]
10. A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle.
Gonzalez-Serratos H; Chang R; Pereira EF; Castro NG; Aracava Y; Melo PA; Lima PC; Fraga CA; Barreiro EJ; Albuquerque EX
J Pharmacol Exp Ther; 2001 Nov; 299(2):558-66. PubMed ID: 11602667
[TBL] [Abstract][Full Text] [Related]
11. Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581.
Pazini F; Menegatti R; Sabino JR; Andrade CH; Neves G; Rates SM; Noël F; Fraga CA; Barreiro EJ; de Oliveira V
Bioorg Med Chem Lett; 2010 May; 20(9):2888-91. PubMed ID: 20363131
[TBL] [Abstract][Full Text] [Related]
12. Impairment of locomotor activity induced by the novel N-acylhydrazone derivatives LASSBio-785 and LASSBio-786 in mice.
Silva GA; Kummerle AE; Antunes F; Fraga CA; Barreiro EJ; Zapata-Sudo G; Sudo RT
Braz J Med Biol Res; 2013 Mar; 46(3):263-9. PubMed ID: 23558854
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of amrinone in animals.
Baker JF; Chalecki BW; Benziger DP; O'Melia PE; Clemans SD; Edelson J
Drug Metab Dispos; 1982; 10(2):168-72. PubMed ID: 6124404
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of gallic acid by Beauveria sulfurescens ATCC 7159.
Hsu FL; Yang LM; Chang SF; Wang LH; Hsu CY; Liu PC; Lin SJ
Appl Microbiol Biotechnol; 2007 Mar; 74(3):659-66. PubMed ID: 17111140
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of parthenin by Beauveria bassiana ATCC 7159.
Abdel Halim OB; Maatooq GT; Marzouk AM
Pharmazie; 2007 Mar; 62(3):226-30. PubMed ID: 17416201
[TBL] [Abstract][Full Text] [Related]
16. Structure determination of two new monocillin I derivatives.
Zhan J; Wijeratne EM; Gunatilaka AA
Nat Prod Commun; 2010 May; 5(5):801-4. PubMed ID: 20521550
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the conformational ensemble from bioactive N-acylhydrazone derivatives.
Pol-Fachin L; Fraga CA; Barreiro EJ; Verli H
J Mol Graph Model; 2010 Jan; 28(5):446-54. PubMed ID: 19942466
[TBL] [Abstract][Full Text] [Related]
18. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
19. Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
Mendes TC; Raimundo JM; Nascimento-Junior NM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Pharmacol Biochem Behav; 2009 Nov; 94(1):70-4. PubMed ID: 19635495
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and cardiotonic activity of imidazo[2,1-b]thiazole guanylhydrazones.
Andreani A; Rambaldi M; Locatelli A; Bossa R; Galatulas I; Salvatore G
In Vivo; 1994; 8(6):1031-2. PubMed ID: 7772733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
